Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

Elon Musk, CEO of Tesla and SpaceX, shared his dramatic weight loss attributed to the GLP-1 inhibitor Mounjaro, used ...

GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their developers with both rich remuneration and scientific acclamation. There are now ...

Plenty of people want to lose weight in 2025, but here's why many may actually get there thanks to GLP-1 drugs.

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

Losing weight on a GLP-1 can lead to muscle loss, research shows. Here, obseity experts share how to preserve your lean ...

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

Two SciFri producers discuss the year’s most intriguing stories, from new weight-loss drugs to PFAS chemicals to the ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...